1. Home
  2. DCTH vs TLRY Comparison

DCTH vs TLRY Comparison

Compare DCTH & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DCTH

Delcath Systems Inc.

HOLD

Current Price

$14.42

Market Cap

578.4M

Sector

Health Care

ML Signal

HOLD

Logo Tilray Brands Inc.

TLRY

Tilray Brands Inc.

HOLD

Current Price

$2.81

Market Cap

533.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCTH
TLRY
Founded
1988
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
578.4M
533.5M
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
DCTH
TLRY
Price
$14.42
$2.81
Analyst Decision
Strong Buy
Buy
Analyst Count
5
10
Target Price
★ $24.00
$5.89
AVG Volume (30 Days)
251.9K
★ 3.7M
Earning Date
11-03-2026
10-08-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 107.53
55.69
EPS
★ 0.04
N/A
Revenue
N/A
N/A
Revenue This Year
$24.61
$20.15
Revenue Next Year
$24.27
$5.32
P/E Ratio
$368.38
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.12
$0.77
52 Week High
$17.42
$15.70

Technical Indicators

Market Signals
Indicator
DCTH
TLRY
Relative Strength Index (RSI) 39.08 19.22
Support Level $14.26 N/A
Resistance Level $16.51 $4.91
Average True Range (ATR) 0.51 0.17
MACD -0.06 -0.04
Stochastic Oscillator 17.28 2.12

Price Performance

Historical Comparison
DCTH
TLRY

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About TLRY Tilray Brands Inc.

Tilray is as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. The company portfolio includes brand such as Sweet Water Brewing, Montauk Brewing, Brew Dog, Shock Top, 10 Barrell, Breckenridge Brewery, Blue Point Brewing, Breckenridge Distillery, Revolver, Terrapin, Broken Coast, Good Supply, Redecan, Solei, Tilray, ARX, XMG, Manitoba Harvest and Hi-Ball. The company has four segment Beverage, Cannabis, Distribution and Wellness. The majority of the revenue is generated from Distribution business which encompasses the purchase and resale of pharmaceuticals products to customers.

Share on Social Networks: